Patent Classification

Drug Delivery System, Lipid Related Delivery Systems

1. Pharmaceutical compositions for lipophilic drugs
    
2. Phospholipid-based powders for drug delivery
    
3. Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
    
4. Stable lipid-comprising drug delivery complexes and methods for their production
    
5. Stable lipid-comprising drug delivery complexes and methods for their production
    
6. Lipophilic drug compositions
    
7. Self-assembled lipid bilayer materials
    
8. Lipid matrix-drug conjugates particle for controlled release of active ingredient
    
9. Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process
   
   
10. Methods of delivery using cationic lipids and helper lipids
     
    
11. Phospholipid composition
     
    
12. Incorporation of a water-soluble active principle in a lipid

Drug Delivery System, Liposomes/Lipid Vesicles/Exosomes

1. Liposome-encapsulated glutathione for oral administration
    
2. Gas-containing liposomes
    
3. Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome
    
4. Dispersible concentrate lipospheres for delivery of active agents
    
5. Immunoliposomes that optimize internationalization into target cells
    
6. Encapsulation of aqueous phase systems within microscopic volumes
    
7. MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting
    
8. Liposome loading with metal ions
    
9. Liposomes coated with selected antibodies that bind to aminophospholipids
    
10. Encapsulation of bioactive complexes in liposomes
     
11. Liposome for incorporating large amounts of hydrophobic substances
     
12. Targeted drug delivery with a hyaluronan ligand
     
13. Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
     
14. Liposome drug delivery
     
15. Liposomes
     
16. Liposomal analgesic drug compositions prepared in GMV using an ammonium sulfate gradient
     
17. Method of encapsulating metal complex within liposomes
     
18. Small particle liposome aerosols for delivery of anticancer drugs
     
19. Small particle liposome aerosols for delivery of anti-cancer drugs
     
20. High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them
     
21. Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
     
22. Method of administering liposomal encapsulated taxane
     
23. Liposome complexes for increased systemic delivery
     
24. Liposome-entrapped topoisomerase inhibitors
     
25. Submicron liposome suspensions obtained from preliposome lyophilizates
     
26. Protein-stabilized liposomal formulations of pharmaceutical agents
     
27. Methods and compositions for delivering macromolecules to or via the respiratory tract
     
28. Cationic lipid compositions targeting angiogenic endothelial cells
     
29. Compositions for receptor/liposome mediated transfection and methods of using same
     
30. Liposomal formulation of irinotecan
     
31. Cationic liposome delivery of taxanes to angiogenic blood vessels
     
32. Liposome compositions and methods for the treatment of atherosclerosis
     
33. Methods for preparation of lipid-encapsulated therapeutic agents
     
34. Non-invasive gene targeting to ocular cells
     
35. Application of lipid vehicles and use for drug delivery
     
36. Functionalized encapsulated fluorescent nanocrystals
     
37. Liposomal camptothecins and uses thereof
     
38. Carotenoid-loaded liposomes
     
39. Reversible masking of liposomal complexes for targeted delivery
     
40. Liposomes
     
41. β-glucans encapsulated in liposomes
     
42. Liposome containing hydrophobic iodine compound and X-ray contrast medium for radiograph comprising the liposome
     
43. Liposome complexes for increased systemic delivery
     
44. Temperature sensitive control of liposome-cell adhesion
     
45. Radiation sensitive liposomes
     
46. Temperature controlled content release from liposomes
     
47. Iron chelator delivery system
     
48. Liposomal analgesic formulation and use
     
49. Pharmaceutical composition comprising factor VIII and neutral liposomes
     
50. Liposomak compositions and methods of preparation
     
51. Amphiphilic polymeric vesicles
     
52. Hyaluronic drug delivery system
     
53. Proliposomal drug delivery system
     
54. Compositions and methods for topical delivery of oligonucleotides
     
55. Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
     
56. Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
     
57. Methods of producing membrane vesicles
     
58. Liposome complexes for increased systemic delivery
     
59. Use of complexes among cationic liposomes and polydeoxyribonucleotides and medicaments
     
60. Targeted liposome gene delivery
     
61. Methods for encapsulating nucleic acids in lipid bilayers
     
62. Gene-entrapped liposomes preparation and process for the preparation thereof
     
63. Temperature-sensitive liposomal formulation
     
64. Reconstitution of purified membrane proteins into preformed liposomes
     
65. Vasopermeability-enhancing conjugates
     
66. Pain management with liposome-encapsulated analgesic drugs
     
67. Drug delivery formulations and targeting
     
68. Liposome having an exchangeable component
     
69. Liposomal vector for active-principle
     
70. Low-rigidity liposomal formulation
     
71. Use of liposomes of defined composition and size for the preparation of prothrombin time reagents
     
72. Compositions for receptor/liposome mediated transfection and methods of using same
     
73. Cationic liposomal delivery system and therapeutic use thereof
     
74. Multilamellar coalescence vesicles (MLCV) containing biologically active compounds
     
75. Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
     
76. Pharmaceuticals and assays using enzyme subunits
     
77. Method of loading preformed liposomes using ethanol
     
78. pH-sensitive, serum-stable liposomes
     
79. Fusogenic liposomes
     
80. Liposome complexes for increased systemic delivery
     
81. Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
    
    
82. Stabilization of photosensitive materials
    
    
83. Liposomes comprising peptide antigens derived from X protein of hepatitis B virus
    
    
84. Non-invasive gene targeting to the brain
    
    
85. Steroidal liposomes
    
    
86. Stabilization of taxane-containing dispersed systems
    
    
87. Composition for treating cancer via liposomal aerosol formulation containing taxol
    
    
88. Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
     
    
89. Liposomal aerosols for delivery of chemotherapeutic retinoids to the lungs
     
    
90. Powder compositions of unilamellar liposomes
     
91. Enhanced circulation effector composition and method
     
    
92. Therapeutic liposome composition and method of preparation
     
    
93. Lipid complexes and liposomes of highly insoluble platinum complexes
     
    
94. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
     
    
95. Sonic nebulized nucleic acid/cationic liposome complexes and methods for pulmonary gene delivery
     
    
96. Delivery of biologically active substance to target sites in the body of patients
     
    
97. Glucoside paucilamellar vesicles
     
    
98. Reconstitution of purified membrane proteins into preformed liposomes
     
    
99. Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
     
    
100. Drug delivery via therapeutic hydrogels
      
     
101. Polymer-lipid conjugate for fusion of target membranes
      
     
102. Method for delivering beneficial compositions to hair follicles 
      
     
103. Use of virulence factors of pathogens to improve liposomal delivery of therapeutic agents
      
     
104. Immunoliposomes that optimize internalization into target cells
      
     
105. Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
      
     
106. Method for inducing a systemic immune response to an HIV antigen
      
     
107. Biocompatible surfaces and a method for their preparation
      
     
108. Temperature-sensitive liposomal formulation
      
     
109. Proteinic drug delivery system using membrane mimetics
      
     
110. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
      
     
111. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
      
     
112. Masking of liposomes from RES recognition
      
     
113. Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
      
     
114. Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells
      
     
115. Method for high loading of vesicles with biopolymeric substances
      
     
116. Liposome encapsulated amphiphilic drug compositions
      
     
117. Method of administering liposomal encapsulated taxane
      
     
118. Liposomes containing active agents
      
     
119. Liposome compositions and methods for the treatment of atherosclerosis
      
     
120. Targeted polymerized liposome diagnostic and treatment agents
      
     
121. Drug delivery via therapeutic hydrogels
      
     
122. Multivesicular liposomes with controlled release of encapsulated biologically active substances
      
     
123. Liposomes containing a cisplatin compound
      
     
124. Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
      
     
125. Cationic lipid compositions targeting angiogenic endothelial cells
      
     
126. Liposomal delivery system for biologically active agents
      
     
127. Compound-loaded liposomes and methods for their preparation
      
     
128. Modulation of drug loading in multivescular liposomes
      
     
129. Stabilization of lipid:DNA formulations during nebulization
      
     
130. Process for the preparation of liposomes without the use of an organic solvent
      
     
131. Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
      
     
132. Liposome-mediated transfection of central nervous system cells
      
     
133. Liposomal oligonucleotide compositions
      
     
134. Potentiation of immune responses with liposomal adjuvants
      
     
135. Small particle liposome aerosols for delivery of anti-cancer drugs
      
     
136. Liposomal delivery of AAV vectors
      
     
137. Liposome encapsulated active agent dry powder composition
      
     
138. High drug:lipid formulations of liposomal-antineoplastic agents
      
     
139. Liposomal transfection method
      
     
140. Multivesicular liposomes with controlled release of active agents encapsulated in the presence of a hydrochloride
      
     
141. Lipid vesicles formed with alkylammonium fatty acid salts
      
     
142. Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
      
     
143. Targeted liposomal constructs for diagnostic and therapeutic uses
      
     
144. Liposomal products
      
     
145. Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
      
     
146. Therapeutic liposome composition and method of preparation
      
     
147. Liposome loading method using a boronic acid compound
      
     
148. Liposomal delivery by iontophoresis
      
     
149. Sustained-release liposomal anesthetic compositions
      
     
150. Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides
      
     
151. Therapeutic liposome composition and method
      
     
152. Pharmaceutical compositions, novel uses, and novel form of .alpha.-tocopherylphosphocholine
      
     
153. Process for making liposomal ion-exchange whey protein and products thereof
      
     
154. Detection of endotoxin levels in liposomes, lipid bilayers and lipid complexes
      
     
155. Process for making liposome preparation
      
     
156. Targeted polymerized liposomes for improved drug delivery
      
     
157. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
      
     
158. Cationic lipids and methods of use therefore
      
     
159. Aminophospholipid compositions and uses thereof
      
     
160. Liposome composition and method for administering a quinolone
      
     
161. Use of liposome encapsulated cirprofloxacin as an immunotherapeutic drug
      
     
162. Etherlipid-containing multiple lipid liposomes
      
     
163. Liposomal-polyene preliposomal powder and method for its preparation
      
     
164. Amphotericin B liposome preparation
      
     
165. Liposome eye drops
      
     
166. Application of SOD in liposomes
      
     
167. Etherlipid containing multiple lipid liposomes
      
     
168. Liposome drug-loading method and composition
      
     
169. Polymer-associated liposomes for drug delivery and method of manufacturing the same
      
     
170. Methods of preparing gas-filled liposomes
      
     
171. Liposomal human calcitonin gene-related peptide composition and preparation of the same
      
     
172. Stabilized liposomes
      
     
173. Multivesicular liposomes utilizing neutral lipids to modify in vivo release

Drug Delivery System, Liquisolid/Liquid Crystals

1. Nimesulide topical formulations in the form of liquid crystals
    
   
2. Liquid crystalline phase drug delivery vehicle
    
   
3. Liquisolid systems and methods of preparing same
    
   
4. Liquisolid systems and methods of preparing same

Drug Delivery System, Localized Delivery

1. Compositions and techniques for localized therapy
    
2. High efficiency local drug delivery
   
   
3. Methods for the localized delivery of agents to blood vessels

Drug Delivery System, Low/Micro Dose

1. Microdose therapy
    
   
2. Method for preparing low dose pharmaceutical products

Drug Delivery System, Lozenges

1. Throat lozenge for the treatment of Streptococcus Group A
    
2. Throat lozenges for the treatment of Hemosphilus influenza
    
3. Ambroxol-containing lozenge
    
4. Antiarrhythmic and tranquilizer composition and treatment
    
5. Dextrose-based lozenges and process for their manufacture
    
6. Nicotine lozenge
    
   
7. Lozenge for the modified releasing of active substances in the gastrointestinal tract
    
   
8. Lozenge and method of making
    
   
9. Process for making flurbiprofen lozenges

Drug Delivery System, Magnetic

1. Composite beads comprising magnetizable substance and electro-conductive substance
    
2. Microencapsulation of magnetic material using heat stabilization
    
3. Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
    
4. Magnetically responsive composition
    
5. Magnetically responsive compositions for carrying biologically active substances and methods of production and use

Drug Delivery System, Marking

1. Marking of orally ingested products

Drug Delivery System, Matrix, Porous/Nonporous

1. Ion-strength independent sustained release pharmaceutical formulation
    
2. Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
    
3. Delivery systems for functional ingredients
    
4. Cell scaffold matrices with incorporated therapeutic agents
    
5. Methods and compositions for deterring abuse of opioid containing dosage forms
    
6. Porous paclitaxel matrices and methods of manufacture thereof
    
7. Controlled release and taste masking oral pharmaceutical composition
    
8. Medicament incorporation matrix
    
9. Polymeric drug formulations
    
10. Porous drug matrices and methods of manufacture thereof
     
11. Porous COX-2 inhibitor matrices and methods of manufacture thereof
     
12. Membrane or matrix for controlling the permeation rate of drugs
     
13. Mesalazine controlled release oral pharmaceutical compositions
     
14. Collagen/polysaccharide bilayer matrix
     
15. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
     
16. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
     
17. Mesoporous compositions and method of preparation
     
18. Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
     
19. Matrix material containing sugars and/or sugar alcohols and process for its preparation
     
20. Once-a-day controlled release sulfonylurea formulation
     
21. Controlled release formulation of divalproex sodium
     
22. Method of manufacturing porous matrix-type controlled release systems using emulsion technique

Drug Delivery System, Medicated Candy

1. Drug storage and delivery system containing a medicated lollipop

Drug Delivery System, Micelle

1. Micellar drug delivery systems for hydrophobic drugs
    
2. Micelles
    
3. Cross-linked ionic core micelles
    
4. pH-sensitive polymeric micelles for drug delivery
    
5. Stable polymeric micelle-type drug composition and method for the preparation thereof
    
6. pH-sensitive block copolymers for pharmaceutical compositions
    
7. Micellar systems
    
8. Methods of administering and enhancing absorption of pharmaceutical agents
    
9. Pro-micelle pharmaceutical compositions
    
10. Biocleavable micelle compositions for use as drug carriers
     
11. Microemulsion and micelle systems for solubilizing drugs
     
12. Microemulsion and micelle systems for solubilizing drugs
     
13. Reverse micelles for delivery of nucleic acids
     
14. Polymeric micelle compositions
     
    
15. Materials and methods for making improved micelle compositions
     
16. Mixed micellar delivery system and method of preparation
     
    
17. Biodegradable mixed polymeric micelles for gene delivery
     
    
18. Lock and key micelles
     
    
19. Emulsion and micellar formulations for the delivery of biologically active substances to cells
     
    
20. Mixed micellar delivery system and method of preparation

Drug Delivery System, Microcrystal/Crystal/Polymorph

1. Crystalline form for quinapril hydrochloride and process for preparing the same
    
2. Stable shaped particles of crystalline organic compounds
    
3. Small particle-adjustment crystallization process
    
4. Crystal forms of azithromycin
    
5. Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
    
6. Particles coated with granulated crystalline ibuprofen
    
7. Stable shaped particles of crystalline organic compounds
    
8. Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
    
9. Opioid analgesics with controlled active substance release
    
10. Stable shaped particles of crystalline organic compounds
     
11. Insoluble insulin compositions
     
    
12. Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use

Drug Delivery System, Micro/Nano Emulsion

1. Dispersions of microemulsions in hydrogels for drug delivery
    
2. Cyclosporin analog formulations
    
3. Waterless lotion and lotion-treated substrate
    
4. Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
    
5. Microemulsion and micelle systems for solubilizing drugs
    
6. Microemulsion and micelle systems for solubilizing drugs
    
7. Microemulsion aerosol composition
    
8. Stable microemulsions for the administration of fatty acids to humans or to animals, and use of these microemulsions
    
9. Nanoemulsion based on oxyethylenated or non-oxyethylenated sorbitan fatty esters, and its uses in the cosmetics, dermatological and/or ophthalmological fields
    
   
10. Orally administrable composition capable of providing enhanced bioavailability when ingested
     
    
11. Composition with sustained release of active principle, capable of forming a microemulsion
     
    
12. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
     
    
13. Microemulsion
     
    
14. Microemulsions as solid dosage forms for oral administration
     
    
15. Nanoemulsion based on phosphoric acid fatty acid esters and its uses in the cosmetics, dermatological, pharmaceutical, and/or ophthalmological fields
     
    
16. Drug delivery compositions suitable for intravenous injection
     
    
17. Nutrient microemulsion in spray form, useful as a biodegradation accelerator
     
    
18. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
     
    
19. Microemulsion
     
    
20. Method of preparing silicone oil-in-water microemulsions
     
    
21. Cyclosporin-containing microemulsion preconcentrate composition
     
    
22. Orally administrable composition capable of providing enhanced bioavailability when ingested
     
    
23. Water-based microemulsion of a pyrethroid
     
    
24. Microemulsion preconcentrates comprising cyclosporins
     
    
25. Water-dilutable, microemulsion concentrate and pour-on formulations thereof

Drug Delivery System, Microencapsulation

1. Method of microencapsulation
    
2. Microencapsulated heat delivery vehicles
    
3. Microencapsulated materials and method of making same
    
4. Controlled release microencapsulated NGF formulation
    
5. Microencapsulation and sustained release of biologically active polypeptides
    
6. Methods of administering microencapsulated materials for immune modulated diseases
    
7. Aquespheres, their preparation and uses thereof
    
8. Microencapsulation of magnetic material using heat stabilization
    
9. Sustained-release microencapsulated delivery system
    
10. Method of microencapsulation
     
11. Compositions for microencapsulation of antigens for use as vaccines
     
12. Composite nanospheres and their conjugates with biomolecules
     
13. Encapsulation method
     
14. Composition comprising micro-encapsulated iron
     
15. Process for microencapsulation of water soluble substances
     
16. Composition and method for the encapsulation of water-soluble molecules into nanoparticles
     
17. Microencapsulated plasminogen activators
     
18. Microencapsulation and sustained release of oligonucleotides
     
19. Organic compounds
     
    
20. Oral therapy for the treatment of allergies and method of manufacture
     
    
21. Encapsulation of oleophilic substances and compositions produced thereby
     
    
22. Water-in-oil microencapsulation process and microcapsules produced thereby
     
    
23. Method for microencapsulating a solid substance
     
    
24. Controlled release microencapsulated NGF formulation
     
    
25. Microencapsulation and electrostatic processing method
     
    
26. Pharmaceutical microencapsulation

Drug Delivery System, Microencapsulation, Cells/DNA/Biomaterial

1. Multi-layer cell encapsulation for tissue engineering
    
2. Preparation of agarose coated, solid agarose beads containing secretory cells
    
3. Methods and gel compositions for encapsulating living cells and organic molecules
    
4. Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same
    
5. Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials
    
6. Alginate capsules for use in the treatment of brain tumor
    
7. Multi-layer cell encapsulation for tissue engineering
    
8. Microencapsulated pancreatic islet cells
    
9. Encapsulated cells producing viral particles
    
10. Method of making microencapsulated DNA for vaccination and gene therapy
     
11. Method for gene therapy using nucleic acid loaded polymeric microparticles
     
12. Preparing small microcapsules containing high concentration of cells or tissue
     
13. Encapsulated cells producing antibodies
     
14. Methods of culturing and encapsulating pancreatic islet cells
    
    
15. Method of making microencapsulated DNA for vaccination and gene therapy
     
    
16. Process for microencapsulating cells
     
    
17. Process for microencapsulating cells